Baker Bros. Advisors »

Alumis shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $17M 1.6M 10.68
2024-06-30 $21M 1.6M 13.30

More positions owned by Baker Bros. Advisors

BeiGene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Kymera Therapeutics (KYMR)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Replimune Group (REPL)
Alkermes SHS (ALKS)
Denali Therapeutics (DNLI)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)

View all positions for Baker Bros. Advisors

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
Cormorant Asset Management
Sr One Capital Management
Baker Bros. Advisors
Nextech Invest
BlackRock
Omega Fund Management
Tang Capital Management
TowerView
Morgan Stanley
Geode Capital Management
Iron Triangle Partners

View all funds holding Alumis